COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • January 29th, 2007 • Oncogenex Technologies Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 29th, 2007 Company Industry JurisdictionTHIS COLLABORATION AND LICENSE AGREEMENT (“Agreement”) is made and entered into effective as of January 5, 2005 (the “Effective Date”), by and among ONCOGENEX TECHNOLOGIES INC., having offices at #400 – 1001 West Broadway, Vancouver, B.C., V6H 4B1 (“OncoGenex”) and ISIS PHARMACEUTICALS, INC., having principal offices at 2292 Faraday Avenue, Carlsbad CA 92008 (“Isis”). OncoGenex and Isis each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • December 13th, 2006 • Oncogenex Technologies Inc • Delaware
Contract Type FiledDecember 13th, 2006 Company JurisdictionTHIS COLLABORATION AND LICENSE AGREEMENT (“Agreement”) is made and entered into effective as of January 5, 2005 (the “Effective Date”), by and among ONCOGENEX TECHNOLOGIES INC., having offices at #400 – 1001 West Broadway, Vancouver, B.C., V6H 4B1 (“OncoGenex”) and ISIS PHARMACEUTICALS, INC., having principal offices at 2292 Faraday Avenue, Carlsbad CA 92008 (“Isis”). OncoGenex and Isis each may be referred to herein individually as a “Party,” or collectively as the “Parties.”